MSB 2.17% $1.13 mesoblast limited

FDA guidelines state that in the absence of any endpoint,...

  1. 308 Posts.
    lightbulb Created with Sketch. 76
    FDA guidelines state that in the absence of any endpoint, mortality reduction is the golden factor.
    now add endpoints being met alongside a huge reduction in mortality, repeatedly, FDA will be keeping a close eye on CHF.
    i believe AA this year based on the FDA comments with a confirmatory trial commencing once conditional approval is given.
    CHF could be the sleeping giant

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.